Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

BuzzBack to Present New Diabetes Research in Poster Session at The PMRG Institute

Posted on: 03 Jul 12
BuzzBack to Present New Diabetes Research  in Poster Session at The PMRG Institute

New York, NY (July 3 2012) BuzzBack, an innovator in online market research, today announced participation at The PMRG Institute in Philadelphia, October 14-16, 2012. The session will highlight new diabetes research: issues around the disease, day-to-day behaviors, and feelings among sufferers and physicians. Carol Fitzgerald, President of BuzzBack Market Research will present.

Type 2 Diabetes is growing at an alarming rate globally with over 430 million adults expected to be impacted by the disease by 20301. As a result, many companies are focused on finding solutions. Fielded in January 2012, BuzzBack’s study surveyed patients of type 2 diabetes taking oral medication and doctors and endocrinologists treating the same in the US and UK. Highlights of the research reveal:

  • Weight, diet and exercise represent key day-to-day challenges of people living with type 2 diabetes
  • The majority of patients say they’re generally managing well, but the majority of doctors say the opposite
  • Living with diabetes causes sufferers to feel burdened, trapped, worried and anxious; doctors understand some these factors, but also see compliance as an underlying issue
  • Three quarters’ say doctors are most influential in the treatments they choose to treat type 2 diabetes; doctors rely on clinical proof to make patient recommendations
  • Top oral medications patients currently take include Metformin and Glucophage, though doctors prescribing these treatments may change their selections in the future
”Diabetes is an epidemic,” says Fitzgerald. “We conducted this research because we have many clients working on products for people with type 2 diabetes – from pharmaceutical companies to food and beverage suppliers. Our new research reinforces some of the current behavioral challenges, but it also reveals new learning around emotions and other motivational factors critical in driving patient and physician behavior and attitudes. It will provide important context and understanding for marketers focused on this growing population.”

For more information about the study, or to receive a copy of the report, email or visit to learn more. For more information about PMRG, visit

About BuzzBack
Since our founding in 2000, BuzzBack has been a pioneer in developing online research techniques that provide richer understanding, depth and emotional insights. We help today’s leading and emerging consumer, technology, pharmaceutical and financial services companies successfully connect to consumers, as well as optimize concepts and new product ideas. We conduct research in 25+ countries and both our techniques and researchers have been recognized by the industry, with numerous awards from the ARF, MRS/ASC, and ESOMAR. BuzzBack is a woman-owned diversity supplier with WBENC certification.

¹Driscoll, P. “The Growing Need for Diabetes Management Globally.” MedMarket Diligence, 10 September 2010. (

For more information:

Editor's Details

Melanie Degnan

Last updated on: 03/07/2012

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.